Hem › Crohns sjukdom › Iowa
Kliniska studier för Crohns sjukdom i Iowa
8 studier för Crohns sjukdom söker deltagare vid platser i Iowa.
Städer i Iowa
Officiell studietext (engelska)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Iowa Digestive Disease Center ( Site 5007), Clive
RekryterarFas 3
Ålder 16 till 80 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06430801A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Heartland Medical Research Inc, Clive
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07499232A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- The University of Iowa Hospitals & Clinics, Iowa City
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06233461An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Heartland Medical Research, Inc.-Site Number: 8400134, Clive
- Digestive Health Research Center-Site Number: 8400096, Waterloo
RekryterarFas 3
Ålder 16 till 80 · Alla kön · Uppdaterad 23 sep. 2026 · NCT07184931Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- University of Iowa, Iowa City
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 5 aug. 2026 · NCT07237516Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- University of Iowa Health Care, Iowa City
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 27 apr. 2026 · NCT06456593A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400025, Iowa City
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 27 mars 2026 · NCT06958536Treatment of Moderate to Severe Refractory Crohn's Disease
- University of Iowa, Iowa City
RekryterarFas 1/2
Ålder 18 till 65 · Alla kön · Uppdaterad 10 dec. 2025 · NCT06721962Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.